Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel

mRNA technology is currently being investigated for a range of oncology indications. We assessed the willingness to pay (WTP) of the general population in Israel for a hypothetical novel mRNA-based treatment for oncology indications. We used a contingent valuation methodology to elicit WTP using a w...

Full description

Saved in:
Bibliographic Details
Published in:Israel journal of health policy research 2024-02, Vol.13 (1), p.9-9, Article 9
Main Authors: Ben-Aharon, Omer, Sergienko, Ruslan, Iskrov, Georgi, Greenberg, Dan
Format: Article
Language:English
Subjects:
Adoption of innovations
Adult
Cancer
Cancer therapies
Cancer vaccines
Care and treatment
Clinical trials
Consumer spending
Contingent valuation
COVID-19 vaccines
Digestive system
Health care industry
Health care policy
Health insurance
Humans
Immunotherapy
Income
Innovations
Insurance, Health
Intervention
Israel
Jewish people
Lung cancer
Medical care, Cost of
Medical innovations
Medical treatment
Melanoma
Metastasis
MicroRNA
mRNA
mRNA vaccines
Neoplasms - therapy
Oncology
Original
Ovarian cancer
Pharmaceutical industry
Policy making
Questionnaires
Respondents
Surveys
Surveys and Questionnaires
Tumors
Valuation
Willingness to pay
Willingness to pay (WTP)
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:mRNA technology is currently being investigated for a range of oncology indications. We assessed the willingness to pay (WTP) of the general population in Israel for a hypothetical novel mRNA-based treatment for oncology indications. We used a contingent valuation methodology to elicit WTP using a web-based questionnaire. A sample of adult participants were presented with a hypothetical scenario in which an mRNA-based intervention increased the likelihood of a cure for various cancer types from 20% to 40% (half of the sample), or 60% (the other half of the sample). 531 respondents completed the questionnaire. The mean, median and mode WTP for the proposed hypothetical treatment in both scenarios were ILS65,000 (± ILS114,000), ILS20,000 and ILS50,000, respectively (1USD = 3.4ILS). The WTP was skewed towards zero, and 9.6% of the respondents were not willing to pay any amount. WTP higher amounts was significantly associated with higher income (p 
ISSN:2045-4015
2045-4015
DOI:10.1186/s13584-024-00594-z